Botox Linked To Adverse Reactions, Sometimes Death, Says FDA

Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been associated with undesirable side-effects, including respiratory failure, and on occasions death, says the US Food and Drug Administration (FDA). These adverse reactions can occur after treatment for a range of conditions and dosages. These reactions may be caused by overdosing, the FDA reports in an early communication based on its ongoing safety review.

More: continued here

Filed under: Neurology / Neuroscience on February 11th, 2008